Vera Therapeutics INC
-$832.1M
Net Activity
Institutions Holding
229
Popularity Rank
#2569
Avg Weight
0.27%
Total Value
$2.9B
229 institutions currently hold VERA, with 135 net buyers and 97 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
97
Net Buying Institutions
135
Top 5 by Value
+$1.3B
Total Buy Value
$2.0B
Total Sell Value
135
Net Buyers
97
Net Sellers
1
Filings (90d)
$2.84M
Total Est. Value
74K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Fordyce Marshall | 2026-06-23 | $2.84M |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
2
Filings (14d)
Vera Therapeutics announced on July 9, 2026 that effective August 3, 2026, William Turner will step down as Chief Regulatory Officer and transition to Special Advisor for Regulatory Affairs. Dr. Nancy Bowman will succeed him as Chief Regulatory Officer. The change was reported in an 8-K filing.
View Full Filing (SEC EDGAR)No AI summary for this filing type
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter